CEA-specific fluorescent imaging in the three cell lines showed that the tumor fluorescence signal appeared in MKN-45 and SNU-16 in a CEA expression-dependent manner at 48 h after SGM-101 administration. The gene discussed is CEACAM5; the disease is neoplasm.